153
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels

, , , , , , , , & show all
Pages 1283-1289 | Published online: 06 Jul 2015

References

  • AgustíAGNogueraASauledaJSalaEPonsJBusquestsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
  • ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: Role of comorbiditiesEur Respir J20062861245125717138679
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2010Global Initiative for Chronic Obstructive Lung Disease, Inc2010 [cited April 1, 2011]. Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdfAccessed April 1, 2011
  • CooperRGEffect of tobacco smoking on renal functionIndian J Med Res2006124326126817085829
  • McAlisterFAEzekowitzJTonelliMArmstrongPWRenal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort studyCirculation200410981004100914769700
  • GoASChertowGMFanDMcCullochCEHsuCYChronic kidney disease and the risks of death, cardiovascular events, and hospitalizationN Engl J Med2004351131296130515385656
  • ManjunathGTighiouartHIbrahimHLevel of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the communityJ Am Coll Cardiol2003411475512570944
  • van GestelYRChoncholMHoeksSEAssociation between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patientsNephrol Dial Transplant20092492763276719369691
  • TerzanoCContiVDi StefanoFComorbidity, hospitalization, and mortality in COPD: results from a longitudinal studyLung2010188432132920066539
  • CasanovaCde TorresJPNavarroJMicroalbuminuria and hypoxemia in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018281004101020558625
  • IncalziRACorsonelloAPedoneCChronic renal failure: a neglected comorbidity of COPDChest2010137483183719903974
  • ChandraDStammJAPalevskyPMThe relationship between pulmonary emphysema and kidney function in smokersChest2012142365566222459775
  • CorsonelloAAntonelli IncalziRPistelliRPedoneCBustacchiniSLattanzioFComorbidities of chronic obstructive pulmonary diseaseCurr Opin Pulm Med201117Suppl 1S21S2822209926
  • HojsRBevcSAntolincBGorenjakMPuklavecLSerum cystatin C as an endogenous marker of renal function in the elderlyInt J Clin Pharmacol Res2004242–3495415689051
  • CollEBoteyAAlvarezLSerum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairmentAm J Kidney Dis2000361293410873868
  • DharnidharkaVRKwonCStevensGSerum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysisAm J Kidney Dis200240222122612148093
  • YashiroMKamataTSegawaHKadoyaYMurakamiTMusoEComparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney diseaseClin Exp Nephrol200913659860419585181
  • HojsRBevcSEkartRGorenjakMPuklavecLSerum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney functionNephrol Dial Transplant20062171855186216524933
  • HojsRBevcSEkartRGorenjakMPuklavecLSerum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney diseaseNephron Clin Pract20101142c118c12619887832
  • VupputuriSFoxCSCoreshJWoodwardMMuntnerPDifferential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass indexAm J Kidney Dis2009536993100119394726
  • MatsuoSImaiEHorioMRevised equations for estimated GFR from serum creatinine in JapanAm J Kidney Dis200953698299219339088
  • HorioMImaiEYasudaYWatanabeTMatsuoSCollaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in JapanAm J Kidney Dis201361219720322892396
  • LeveyASde JongPECoreshJThe definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference reportKidney Int2011801172821150873
  • SchiffrinELLipmanMLMannJFChronic kidney disease: effects on the cardiovascular systemCirculation20071161859717606856
  • KoenigWTwardellaDBrennerHRothenbacherDPlasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rateClin Chem200551232132715563478
  • ShlipakMGKatzRSarnakMJCystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney diseaseAnn Intern Med2006145423724616908914
  • LeeMSaverJLHuangWHChowJChangKHOvbiageleBImpact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysisCirc Cardiovasc Qual Outcomes20103667568320923994
  • KiyosueAHirataYAndoJPlasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney diseaseCirc J201074112441244720921817
  • PeraltaCAKatzRSarnakMJCystatin C identifies chronic kidney disease patients at higher risk for complicationsJ Am Soc Nephrol201122114715521164029
  • DammanKvan der HarstPSmildeTDUse of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failureHeart201298431932422038544